Digital Pathology Market: Segments: By Product (Software, Scanner, Communication Systems, Storage Systems); By Application (Disease Diagnosis, Teleconsultation, Drug Discovery, Training & Education); By End User (Pharmaceutical & Biotechnology Companies, Hospitals and Clinics, Academics Institutes & Research Laboratories); and Region – Global Analysis of Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2030
Product Overview
Digital pathology requires digital format management, sharing, acquisition, and interpretation of pathology content. With a scanning system that offers a high-resolution digital image, glass slides are scanned. On a computer or mobile device, this visual image is then displayed. Technologically advanced optical pathology scanners, which can capture high-quality images of whole glass slides, are available on the market. These slides can then be shared remotely through digital pathology software applications over various networks. Among other uses, the digitalization of pathology has contributed to the automation of research during disease diagnosis.
Market Highlights
Digital Pathology Market is expected to project a notable CAGR of 13.5% in 2030.
The main factors driving the growth of the global digital pathology market are some of the primary factors, such as the efficient cost of digital pathology products, the ease of virtual transport of slides, and the high performance of digital pathology systems. Moreover, growth in digital pathology adoption relative to traditional pathology diagnosis is driving the et growth. In addition, the increase in initiatives to commercialize cost-effective digital pathology systems is expected to give service providers lucrative growth prospects in the future.
Digital Pathology Market: Segments
Diseases diagnosis segment to grow with the highest CAGR of 12.3% during 2020-30
Digital Pathology Market is segmented by applications as drug discovery, teleconsultation, training & education, and diseases diagnosis. Based on application, the teleconsultation segment held the leading position with a market share of around XX.X% in the Digital Pathology market in 2019 as digital pathology is being widely utilized for consulting the geriatric population. In addition, since the geriatric population is more vulnerable to various chronic diseases, the teleconsultation demand will rise as the aging population grows. Owing to the growing prevalence of viral and bacterial diseases, the application of disease diagnosis is expected to rise at a significant pace in the coming years. Due to the rising prevalence of chronic illnesses, the diagnosis segment is expected to experience the fastest CAGR over the forecast era. Furthermore, the manufacturers' emphasis is on the production of innovative and rapid diagnostic techniques. Due to the high prevalence of the disease coupled with ongoing research initiatives, the cancer cell detection field is expected to show lucrative growth in the disease diagnosis segment over the forecast period.
Pharmaceutical and biotechnology companies to grow with the highest CAGR during 2020-30
Digital Pathology Market is segmented by end-user into academic institutes & research laboratories, hospitals & clinics, and pharmaceutical & biotechnology companies. The Hospitals and Clinics segment has been generating the est revenue throughout the historical and forecast period owing to the increasing adoption of these techniques. Hospitals are adopting digital scanning techniques for faster diagnosis and better patient compliance. The segment of biotech and pharma companies is expected to show steady growth over the forecast period. Increased use of digital pathology in drug production, oncology clinical trials, and preclinical GLP pathology is due to progress. Over the projected era, the rising incidence of cancer and the demand for better treatment options are expected to further fuel the market.
Digital Pathology Market: Market Dynamics
Drivers
Growing Number of Tele-consultations
Teleconsultation seeks to omit the spatial and practical gaps between two or more providers of healthcare that are geographically isolated. It is characterized as remote telecommunications consultation, primarily for the diagnosis or treatment of a patient at locations that are distant from patients or primary doctors. Several hospitals, primary healthcare doctors, private medical practices, and other medical units are introducing teleconsultation facilities. It has therefore proved to be feasible and efficient, potentially lowering costs, offering organizational advantages, and improving the satisfaction of patients. It is also expected that the growing acceptance of telepathology, the increasing investment in healthcare in developed countries, the market penetration of key producers in developing countries, and the increasing emphasis on drug development will drive the market.
Rising Adoption of Digital Pathology to Enhance Lab Efficiency
By lowering costs, reducing processing times, and providing users with access to subject-matter knowledge, digital pathology helps boost lab performance. Laboratory quality improvements are important because patients and doctors rely on laboratory outcomes for medical decisions, and diagnostic tests need to be performed and recorded quickly and accurately. In addition, access via web services to digital slides reduces shipping costs and the travel time of pathologists. The outbreak of the COVID-19 pandemic has led to the introduction of certain constraints that have intensified the need for solutions for digital pathology, as these can be used by pathologists to display diagnostic findings remotely for primary diagnosis. A significant number of pathologists and pathology labs are embracing digital pathology to gain a competitive advantage and offer fast services.
Restrain
High cost of digital pathology systems
The development of the digital pathology market is hindered by uncertain reimbursement policies, shortages of trained staff, and the reluctance of older pathologists to embrace modern technologies. While these systems can be afforded by large hospitals with substantial capital budgets, pathologists, and academic institutions with small budgets or IT support often cannot afford them. The high cost of these systems combined with a shortage of trained workers to operate digital pathology systems is expected to restrict the adoption of these systems.
Digital Pathology Market: Key Players
3DHistech Ltd
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, nd SWOT Analysis.
Hamamatsu Photonics KK
Danaher Corporation (Leica Biosystems Nussloch GmbH)
Mikroscan Technologies Inc.
Nikon Corporation
Olympus Corporation
Koninklijke Philips NV
F. Hoffmann-La Roche AG(Ventana Medical Systems Inc.)
Visiopharm AS
Proscia Inc.
Sectra AG
Digital Pathology Market: Regions
Digital Pathology Market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, APAC, and MENA.
Digital Pathology Market in North America held the largest market share of XX.X% in the year 2019 and it is expected to continue its market dominance in the future owing to the continuous implementation of R&D investments, supportive government policies related to the production of technologically advanced technologies, increased use of digital imaging, and the participation of major players. The regional growth is expected to be further fueled by increased use of digital pathology for disease diagnosis coupled with favorable reimbursement policies in the U.S., improving the efficiency of a cancer diagnosis. Due to the increasing penetration of digital imaging in emerging economies, investments in the medical sector, and the existence of untapped opportunities, Asia Pacific is expected to grow at the fastest CAGR during the forecast period. Because of the increased prevalence of cancer, which affects a large population, the Asia Pacific healthcare industry has greatly affected the market. Increasing demand for new treatment options improved care facilities for patients, and lower laboratory costs are also expected to further drive the demand in the ng years.
Competitive Landscape:
Digital Pathology market, which is highly competitive, consists of several major players such as Leica Biosystems (US), Koninklijke Philips N.V. (Netherlands), Hamamatsu Photonics (Japan) hold a substantial market share in the Digital Pathology market. Other players analyzed in this report are Roche (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN (US), Huron Digital Pathology (Canada), Visiopharm A/S (Denmark), Corista (US), Indica Labs (US), Objective Pathology Services (Canada), Sectra AB (Sweden), OptraSCAN (India), Glencoe Software (US), KONFOONG BIOTECH INTERNATIONAL CO., LTD (China), Inspirata, Inc. (US), Mikroscan Technologies (US), Proscia Inc. (US), Kanteron Systems (Spain) among others.
The market competition has been stepped up by the availability of many players offering Digital Pathology. For Instance, in 2019, F. Hoffmann-La Roche Ltd (Switzerland) launched the uPath enterprise software.
Digital Pathology Market is further segmented by region into:
North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
APAC Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, nd Rest of APAC
MENA Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, nd Rest of MENA
Digital Pathology Market report also contains analysis on:
Digital Pathology Market Segments:
By Product:
Software
Scanner
Communication Systems
Storage Systems
By Application:
Disease Diagnosis
Teleconsultation
Drug Discovery
Training & Education
By End-User:
Pharmaceutical & Biotechnology Companies
Hospitals and Clinics
Academics Institutes & Research Laboratories
Digital Pathology Market Dynamics
Digital Pathology Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
FAQs on Digital Pathology Market
Which segment is anticipated to hold the largest market share?
At what CAGR is the market anticipated to grow between 2020 and 2030?
Who are the key players in the Digital Pathology Market?
What could be the challenging factors in the growth of Digital Pathology Market?
What are the growth drivers for the Digital Pathology Market?
Digital pathology requires digital format management, sharing, acquisition, and interpretation of pathology content. With a scanning system that offers a high-resolution digital image, glass slides are scanned. On a computer or mobile device, this visual image is then displayed. Technologically advanced optical pathology scanners, which can capture high-quality images of whole glass slides, are available on the market. These slides can then be shared remotely through digital pathology software applications over various networks. Among other uses, the digitalization of pathology has contributed to the automation of research during disease diagnosis.
Market Highlights
Digital Pathology Market is expected to project a notable CAGR of 13.5% in 2030.
The main factors driving the growth of the global digital pathology market are some of the primary factors, such as the efficient cost of digital pathology products, the ease of virtual transport of slides, and the high performance of digital pathology systems. Moreover, growth in digital pathology adoption relative to traditional pathology diagnosis is driving the et growth. In addition, the increase in initiatives to commercialize cost-effective digital pathology systems is expected to give service providers lucrative growth prospects in the future.
Digital Pathology Market: Segments
Diseases diagnosis segment to grow with the highest CAGR of 12.3% during 2020-30
Digital Pathology Market is segmented by applications as drug discovery, teleconsultation, training & education, and diseases diagnosis. Based on application, the teleconsultation segment held the leading position with a market share of around XX.X% in the Digital Pathology market in 2019 as digital pathology is being widely utilized for consulting the geriatric population. In addition, since the geriatric population is more vulnerable to various chronic diseases, the teleconsultation demand will rise as the aging population grows. Owing to the growing prevalence of viral and bacterial diseases, the application of disease diagnosis is expected to rise at a significant pace in the coming years. Due to the rising prevalence of chronic illnesses, the diagnosis segment is expected to experience the fastest CAGR over the forecast era. Furthermore, the manufacturers' emphasis is on the production of innovative and rapid diagnostic techniques. Due to the high prevalence of the disease coupled with ongoing research initiatives, the cancer cell detection field is expected to show lucrative growth in the disease diagnosis segment over the forecast period.
Pharmaceutical and biotechnology companies to grow with the highest CAGR during 2020-30
Digital Pathology Market is segmented by end-user into academic institutes & research laboratories, hospitals & clinics, and pharmaceutical & biotechnology companies. The Hospitals and Clinics segment has been generating the est revenue throughout the historical and forecast period owing to the increasing adoption of these techniques. Hospitals are adopting digital scanning techniques for faster diagnosis and better patient compliance. The segment of biotech and pharma companies is expected to show steady growth over the forecast period. Increased use of digital pathology in drug production, oncology clinical trials, and preclinical GLP pathology is due to progress. Over the projected era, the rising incidence of cancer and the demand for better treatment options are expected to further fuel the market.
Digital Pathology Market: Market Dynamics
Drivers
Growing Number of Tele-consultations
Teleconsultation seeks to omit the spatial and practical gaps between two or more providers of healthcare that are geographically isolated. It is characterized as remote telecommunications consultation, primarily for the diagnosis or treatment of a patient at locations that are distant from patients or primary doctors. Several hospitals, primary healthcare doctors, private medical practices, and other medical units are introducing teleconsultation facilities. It has therefore proved to be feasible and efficient, potentially lowering costs, offering organizational advantages, and improving the satisfaction of patients. It is also expected that the growing acceptance of telepathology, the increasing investment in healthcare in developed countries, the market penetration of key producers in developing countries, and the increasing emphasis on drug development will drive the market.
Rising Adoption of Digital Pathology to Enhance Lab Efficiency
By lowering costs, reducing processing times, and providing users with access to subject-matter knowledge, digital pathology helps boost lab performance. Laboratory quality improvements are important because patients and doctors rely on laboratory outcomes for medical decisions, and diagnostic tests need to be performed and recorded quickly and accurately. In addition, access via web services to digital slides reduces shipping costs and the travel time of pathologists. The outbreak of the COVID-19 pandemic has led to the introduction of certain constraints that have intensified the need for solutions for digital pathology, as these can be used by pathologists to display diagnostic findings remotely for primary diagnosis. A significant number of pathologists and pathology labs are embracing digital pathology to gain a competitive advantage and offer fast services.
Restrain
High cost of digital pathology systems
The development of the digital pathology market is hindered by uncertain reimbursement policies, shortages of trained staff, and the reluctance of older pathologists to embrace modern technologies. While these systems can be afforded by large hospitals with substantial capital budgets, pathologists, and academic institutions with small budgets or IT support often cannot afford them. The high cost of these systems combined with a shortage of trained workers to operate digital pathology systems is expected to restrict the adoption of these systems.
Digital Pathology Market: Key Players
3DHistech Ltd
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, nd SWOT Analysis.
Hamamatsu Photonics KK
Danaher Corporation (Leica Biosystems Nussloch GmbH)
Mikroscan Technologies Inc.
Nikon Corporation
Olympus Corporation
Koninklijke Philips NV
F. Hoffmann-La Roche AG(Ventana Medical Systems Inc.)
Visiopharm AS
Proscia Inc.
Sectra AG
Digital Pathology Market: Regions
Digital Pathology Market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, APAC, and MENA.
Digital Pathology Market in North America held the largest market share of XX.X% in the year 2019 and it is expected to continue its market dominance in the future owing to the continuous implementation of R&D investments, supportive government policies related to the production of technologically advanced technologies, increased use of digital imaging, and the participation of major players. The regional growth is expected to be further fueled by increased use of digital pathology for disease diagnosis coupled with favorable reimbursement policies in the U.S., improving the efficiency of a cancer diagnosis. Due to the increasing penetration of digital imaging in emerging economies, investments in the medical sector, and the existence of untapped opportunities, Asia Pacific is expected to grow at the fastest CAGR during the forecast period. Because of the increased prevalence of cancer, which affects a large population, the Asia Pacific healthcare industry has greatly affected the market. Increasing demand for new treatment options improved care facilities for patients, and lower laboratory costs are also expected to further drive the demand in the ng years.
Competitive Landscape:
Digital Pathology market, which is highly competitive, consists of several major players such as Leica Biosystems (US), Koninklijke Philips N.V. (Netherlands), Hamamatsu Photonics (Japan) hold a substantial market share in the Digital Pathology market. Other players analyzed in this report are Roche (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN (US), Huron Digital Pathology (Canada), Visiopharm A/S (Denmark), Corista (US), Indica Labs (US), Objective Pathology Services (Canada), Sectra AB (Sweden), OptraSCAN (India), Glencoe Software (US), KONFOONG BIOTECH INTERNATIONAL CO., LTD (China), Inspirata, Inc. (US), Mikroscan Technologies (US), Proscia Inc. (US), Kanteron Systems (Spain) among others.
The market competition has been stepped up by the availability of many players offering Digital Pathology. For Instance, in 2019, F. Hoffmann-La Roche Ltd (Switzerland) launched the uPath enterprise software.
Digital Pathology Market is further segmented by region into:
North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
APAC Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, nd Rest of APAC
MENA Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, nd Rest of MENA
Digital Pathology Market report also contains analysis on:
Digital Pathology Market Segments:
By Product:
Software
Scanner
Communication Systems
Storage Systems
By Application:
Disease Diagnosis
Teleconsultation
Drug Discovery
Training & Education
By End-User:
Pharmaceutical & Biotechnology Companies
Hospitals and Clinics
Academics Institutes & Research Laboratories
Digital Pathology Market Dynamics
Digital Pathology Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
FAQs on Digital Pathology Market
Which segment is anticipated to hold the largest market share?
At what CAGR is the market anticipated to grow between 2020 and 2030?
Who are the key players in the Digital Pathology Market?
What could be the challenging factors in the growth of Digital Pathology Market?
What are the growth drivers for the Digital Pathology Market?
1. EXECUTIVE SUMMARY
2. DIGITAL PATHOLOGY MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MACRO-ECONOMIC INDICATORS
6. MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9. RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. DIGITAL PATHOLOGY ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. DIGITAL PATHOLOGY MARKET
11.1. Market Size & forecast, 2019A-2030F
11.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12. DIGITAL PATHOLOGY: MARKET SEGMENTATION
12.1. By Regions
12.1.1. North America:
12.1.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.2. Europe:
12.1.2.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.3. Asia-Pacific:
12.1.3.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.4. MEA:
12.1.4.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.5. Latin America:
12.1.5.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2. By Product: Market Share (2020-2030F)
12.2.1. Software, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.2. Scanner, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
13. 12.2.1. COMMUNICATION SYSTEMS, BY VALUE (USD MILLION) 2019-2030F; Y-O-Y GROWTH (%) 2020-2030F
14. 12.2.2. STORAGE SYSTEMS, BY VALUE (USD MILLION) 2019-2030F; Y-O-Y GROWTH (%) 2020-2030F
15. 12.3 BY APPLICATION: MARKET SHARE (2020-2030F)
16. 12.3.1. DISEASE DIAGNOSIS, BY VALUE (USD MILLION) 2019-2030F; Y-O-Y GROWTH (%) 2020-2030F
17. 12.3.2. TELECONSULTATION, BY VALUE (USD MILLION) 2019-2030F; Y-O-Y GROWTH (%) 2020-2030F
18. 12.3.3. DRUG DISCOVERY, BY VALUE (USD MILLION) 2019-2030F; Y-O-Y GROWTH (%) 2020-2030F
19. 12.3.3. TRAINING & EDUCATION, BY VALUE (USD MILLION) 2019-2030F; Y-O-Y GROWTH (%) 2020-2030F
20. 12.4 BY END USER: MARKET SHARE (2020-2030F)
21. 12.4.1. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY VALUE (USD MILLION) 2019-2030F; Y-O-Y GROWTH (%) 2020-2030F
22. 12.4.2. HOSPITALS AND CLINICS, BY VALUE (USD MILLION) 2019-2030F; Y-O-Y GROWTH (%) 2020-2030F
23. 12.4.3. ACADEMICS INSTITUTES & RESEARCH LABORATORIES, BY VALUE (USD MILLION) 2019-2030F; Y-O-Y GROWTH (%) 2020-2030F
24. 13. COMPANY PROFILE
25. 3DHISTECH LTD
25.1. Company Overview
25.2. Company Total Revenue (Financials)
25.3. Market Potential
25.4. Global Presence
25.5. Key Performance Indicators
25.6. SWOT Analysis
25.7. Product Launch
26. HAMAMATSU PHOTONICS KK
27. DANAHER CORPORATION (LEICA BIOSYSTEMS NUSSLOCH GMBH)
28. MIKROSCAN TECHNOLOGIES INC.
29. NIKON CORPORATION
30. OLYMPUS CORPORATION
31. KONINKLIJKE PHILIPS NV
32. F. HOFFMANN-LA ROCHE AG(VENTANA MEDICAL SYSTEMS INC.)
33. VISIOPHARM AS
34. PROSCIA INC.
35. SECTRA AG
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
2. DIGITAL PATHOLOGY MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MACRO-ECONOMIC INDICATORS
6. MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9. RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. DIGITAL PATHOLOGY ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. DIGITAL PATHOLOGY MARKET
11.1. Market Size & forecast, 2019A-2030F
11.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12. DIGITAL PATHOLOGY: MARKET SEGMENTATION
12.1. By Regions
12.1.1. North America:
12.1.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.2. Europe:
12.1.2.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.3. Asia-Pacific:
12.1.3.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.4. MEA:
12.1.4.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.5. Latin America:
12.1.5.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2. By Product: Market Share (2020-2030F)
12.2.1. Software, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.2. Scanner, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
13. 12.2.1. COMMUNICATION SYSTEMS, BY VALUE (USD MILLION) 2019-2030F; Y-O-Y GROWTH (%) 2020-2030F
14. 12.2.2. STORAGE SYSTEMS, BY VALUE (USD MILLION) 2019-2030F; Y-O-Y GROWTH (%) 2020-2030F
15. 12.3 BY APPLICATION: MARKET SHARE (2020-2030F)
16. 12.3.1. DISEASE DIAGNOSIS, BY VALUE (USD MILLION) 2019-2030F; Y-O-Y GROWTH (%) 2020-2030F
17. 12.3.2. TELECONSULTATION, BY VALUE (USD MILLION) 2019-2030F; Y-O-Y GROWTH (%) 2020-2030F
18. 12.3.3. DRUG DISCOVERY, BY VALUE (USD MILLION) 2019-2030F; Y-O-Y GROWTH (%) 2020-2030F
19. 12.3.3. TRAINING & EDUCATION, BY VALUE (USD MILLION) 2019-2030F; Y-O-Y GROWTH (%) 2020-2030F
20. 12.4 BY END USER: MARKET SHARE (2020-2030F)
21. 12.4.1. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY VALUE (USD MILLION) 2019-2030F; Y-O-Y GROWTH (%) 2020-2030F
22. 12.4.2. HOSPITALS AND CLINICS, BY VALUE (USD MILLION) 2019-2030F; Y-O-Y GROWTH (%) 2020-2030F
23. 12.4.3. ACADEMICS INSTITUTES & RESEARCH LABORATORIES, BY VALUE (USD MILLION) 2019-2030F; Y-O-Y GROWTH (%) 2020-2030F
24. 13. COMPANY PROFILE
25. 3DHISTECH LTD
25.1. Company Overview
25.2. Company Total Revenue (Financials)
25.3. Market Potential
25.4. Global Presence
25.5. Key Performance Indicators
25.6. SWOT Analysis
25.7. Product Launch
26. HAMAMATSU PHOTONICS KK
27. DANAHER CORPORATION (LEICA BIOSYSTEMS NUSSLOCH GMBH)
28. MIKROSCAN TECHNOLOGIES INC.
29. NIKON CORPORATION
30. OLYMPUS CORPORATION
31. KONINKLIJKE PHILIPS NV
32. F. HOFFMANN-LA ROCHE AG(VENTANA MEDICAL SYSTEMS INC.)
33. VISIOPHARM AS
34. PROSCIA INC.
35. SECTRA AG
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
